Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
First Light Diagnostics Commended by Frost & Sullivan for its MultiPath™ Platform for Infectious Disease Management 2019-04-17 20:00
Senhwa Biosciences Silmitasertib / Basal Cell Carcinoma Trial Completed 1st Patient Enrollment 2019-04-17 19:00
Ping An Wins Three Championships at ISBI with its AI Image Technologies 2019-04-17 18:43
Golden Meditech and HKBU Team Up to Conduct Cell Therapy Research 2019-04-17 17:34
Financial year 2018: Boehringer Ingelheim grows and invests 2019-04-17 16:30
WuXi Biologics Successfully Completed First FDA Routine GMP Inspection 2019-04-17 09:14
MedShift Announces Expansion to Australia and New Zealand 2019-04-17 07:00
I-Mab Biopharma and WuXi Biologics Announce Long-term Strategic Manufacturing Partnership for Five Clinical and One Commercial Programs 2019-04-16 20:39
Hebron Announces Entry into Securities Purchase Agreement and Sets Date for Special Shareholder Meeting 2019-04-16 20:00
WuXi Biologics and I-Mab Biopharma Announce Long-term Strategic Manufacturing Partnership for Five Clinical and One Commercial Programs 2019-04-16 20:00
First patient dosed in Phase III GEMSTONE-303 study for CS1001 in combination with chemotherapy in first-line gastric adenocarcinoma and gastro-esophageal junction adenocarcinoma 2019-04-16 16:58
Analysys Releases Latest Mobile App Ranking: Ping An Good Doctor APP's Market Share Exceeds 70%, Leading The Internet Healthcare Industry 2019-04-16 15:56
Ortho's VITROS® High Sensitivity Troponin I Assay for the Diagnosis of Heart Attack Now CE Marked, Available in EU Countries 2019-04-16 13:55
GC Pharma Marks 'World Hemophilia Day' 2019-04-16 10:57
Tessa Therapeutics Announces Collaboration with Merck Investigating the Combination of KEYTRUDA® (pembrolizumab) and Virus-Specific T Cell Therapy Targeting Human Papillomavirus in Cervical Cancer 2019-04-16 07:15
Tessa Therapeutics Announces Collaboration with MSD Investigating the Combination of KEYTRUDA® (pembrolizumab) and Virus-Specific T Cell Therapy Targeting Human Papillomavirus in Cervical Cancer 2019-04-16 07:15
BioAtla Subsidiary, Himalaya Therapeutics, Will Develop And Commercialize CAB Products In Greater China Market 2019-04-16 06:00
China Jo-Jo Drugstores Announces the Closing of $10 Million Registered Direct Offering 2019-04-16 04:00
Shanghai Pharma Unveils Stock Incentive Plans to Accelerate Global Ambition 2019-04-15 20:00
Ganovo is Eligible for the Basic Medical Insurance of Zhejiang Province - Reimbursement-by-disease 2019-04-15 17:12
1 920 921 922 923 924 1625